Panic Attack and Pheochromocytoma
Referanslar
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. Arlington, VA, American Psychiatric Association, 2013
Kakoki K, Miyata Y, Shida Y, et al. Pheochromocytoma multisystem crisis treated with emergency surgery: a case report and literature review. BMC research notes. 2015;8:758. Published 2015 Dec 9. doi:10.1186/s13104-015-1738-z
Lam AK. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours. Endocrine Pathology. 2017;28(3):213-227. doi:10.1007/s12022-017-9484-5
Pillai S, Gopalan V, Smith RA, et al. Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era Critical reviews in oncology/hematology. 2016;100:190-208. doi:10.1016/j.critrevonc.2016.01.022
Manger WM. The protean manifestations of pheochromocytoma. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2009;41(9):658-663. doi:10.1055/s-0028-1128139
Lenders JW, Eisenhofer G, Mannelli M, et al. Phaeochromocytoma. Lancet. 2005;366(9486):665-675. doi:10.1016/S0140-6736(05)67139-5
Karagiannis A, Mikhailidis DP, Athyros VG, et al. Pheochromocytoma: an update on genetics and management. Endocrine-related cancer. 2007;14(4):935-956. doi:10.1677/ERC-07-0142
Widimský J Jr. Recent advances in the diagnosis and treatment of pheochromocytoma. Kidney & blood pressure research. 2006;29(5):321-326. doi:10.1159/000097262
Moreno AM, Castilla-Guerra L, Martínez-Torres MC, et al. Expression of neuropeptides and other neuroendocrine markers in human phaeochromocytomas. Neuropeptides. 1999;33(2):159-163. doi:10.1054/npep.1999.0012
Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice The Journal of clinical endocrinology and metabolism. 2014;99(6):1915-1942. doi:10.1210/jc.2014-1498
Plouin PF, Gimenez-Roqueplo AP. Pheochromocytomas and secreting paragangliomas. Orphanet journal of rare diseases. 2006;1:49. Published 2006 Dec 8. doi:10.1186/1750-1172-1-49
Janssen OE, Mann K, Erbel R. Das Herz bei endokrinen Erkrankungen [Endocrine disorders and the heart]. Der Internist (Berl). 2007;48(3):246-254. doi:10.1007/s00108-007-1807-z
Munk K, Jønler M. Faeokromocytom debuterende som akut hjerteinsufficiens [Acute cardiac failure in pheochromocytoma]. Ugeskrift for laeger. 2008;170(23):2039.
Zelinka T, Strauch B, Petrák O, et al. Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients. Journal of hypertension. 2005;23(11):2033-2039. doi:10.1097/01.hjh.0000185714.60788.52
Schlaich MP, Kaye DM, Lambert E, et al. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation. 2003;108(5):560-565. doi:10.1161/01.CIR.0000081775.72651.B6
Attar MN, Moulik PK, Salem GD, et al. Phaeochromocytoma presenting as dilated cardiomyopathy. International journal of clinical practice. 2003;57(6):547-548.
Jessurun CR, Adam K, Moise KJ Jr, et al. Pheochromocytoma-induced myocardial infarction in pregnancy. A case report and literature review. Texas Heart Institute journal. 1993;20(2):120-122.
Agarwal V, Kant G, Hans N, Messerli FH. Takotsubo-like cardiomyopathy in pheochromocytoma. International journal of cardiology. 2011;153(3):241-248. doi:10.1016/j.ijcard.2011.03.027
Goldbaum TS, Henochowicz S, Mustafa M, et al. Pheochromocytoma presenting with Prinzmetal's angina. The American journal of medicine. 1986;81(5):921-922.
Shimizu K, Miura Y, Meguro Y, et al. QT prolongation with torsade de pointes in pheochromocytoma. American heart journal. 1992;124(1):235-239. doi:10.1016/0002-8703(92)90954-t
Medvei VC, Cattell WR. Mental symptoms presenting in phaeochromocytoma: a case report and review. Journal of the Royal Society of Medicine. 1988;81(9):550-551. doi:10.1177/014107688808100923
Pacak K, Eisenhofer G, Ahlman H, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nature clinical practice. Endocrinology & metabolism. 2007;3(2):92-102. doi:10.1038/ncpendmet0396
Leigh H. Common Reasons for Psychiatric Consultation In: Leigh H (eds) Handbook of Consultation-Liaison Psychiatry New York: Springer; 2018, p. 37-48
Sadock BJ, Sadock VA, Ruiz P Kaplan & Sadock’s Comprehensive Textbook of Psychiatry (Ali BOZKURT, Ercan DALBUDAK Çev. Ed.). Ankara Güneş Tıp Kitapevi; 2022 p:1723-1784.
Kessler RC, Petukhova M, Sampson NA, et al. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. International journal of methods in psychiatric research. 2012;21(3):169-184. doi:10.1002/mpr.1359
Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of general psychiatry. 2005;62(6):617-627. doi:10.1001/archpsyc.62.6.617
van Loon IN, Lamberts J, Valk GD, et al. The evaluation of spells. The Netherlands journal of medicine. 2011;69(7):309-317.
Beard CM, Sheps SG, Kurland LT, et al. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clinic proceedings. 1983;58(12):802-804.
Fishman MC, Hoffman AR, Klausner RD, et al: Medicine, 5th Edition. Philadelphia, PA, Lip¬pincott Williams & Wilkins, 2004
Stein PP, Black HR. A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience. Medicine (Baltimore). 1991;70(1):46-66. doi:10.1097/00005792-199101000-00004
Kudva YC, Young WF Jr, Thompson GB, et al: Adrenal incidentaloma: an important compo¬nent of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. The Endocrinologist 9(2):77, 1999.
Young WF Jr: Clinical presentation and diagnosis of pheochromocytoma, in UpToDate (website). Edited by Martin KA. Alphen aan den Rijn, The Netherlands, Wolters Kluwer, 2016a.
Young WF Jr: Pheochromocytoma in genetic disorders, in UpToDate (website). Edited by Martin KA. Alphen aan den Rijn, The Netherlands, Wolters Kluwer, 2016b.
